Table 2.
Demographic information based on recurrence status.
| No Recurrence n = 10 | Recurrence n = 17 | p-Value | |
|---|---|---|---|
| Age | 69.8 (11.9) | 61.6 (19.2) | 0.185 |
| Race | 0.215 | ||
| Asian | 0 (0.00%) | 4 (23.5%) | |
| Black | 3 (30.0%) | 2 (11.8%) | |
| White | 7 (70.0%) | 11 (64.7%) | |
| Smoking Status | 0.028 | ||
| Current smoker | 0 (0.00%) | 1 (5.88%) | |
| Former smoker | 6 (75.0%) | 4 (23.5%) | |
| Never smoker | 2 (25.0%) | 12 (70.6%) | |
| Family History of Cancer | 0.613 | ||
| No | 3 (50.0%) | 4 (28.6%) | |
| Yes | 3 (50.0%) | 10 (71.4%) | |
| Mass Laterality | 1.000 | ||
| Bilateral | 4 (40.0%) | 7 (41.2%) | |
| Left | 3 (30.0%) | 6 (35.3%) | |
| Right | 3 (30.0%) | 4 (23.5%) | |
| Stage | 1.000 | ||
| Early Stage: I, II | 2 (20.0%) | 3 (17.6%) | |
| Advanced Stage: III, IV | 8 (80.0%) | 14 (82.4%) | |
| Adjuvant Chemotherapy | 1.000 | ||
| IV | 8 (80.0%) | 11 (73.3%) | |
| IV/IP | 0 (0.00%) | 1 (6.67%) | |
| None | 2 (20.0%) | 3 (20.0%) | |
| Overall Survival (Months) | 29.3 | 12.8 | 0.015 |